CPI | Checkpoint inhibitor |
DLT | Dose-limiting toxicity |
HDAC | Histone deacetylase |
ICI | Immune checkpoint inhibitor |
IDO | Indoleamine 2,3-dioxygenase |
MTD | Maximum tolerated dose |
NSCLC | Non-small cell lung cancer |
ODC | Optimal dose combination |
PARP | Poly-ADP-ribose polymerase |
PD-1 | Programmed death-1 |
PD-L1 | Programmed death ligand-1 |
VEGF | Vascular endothelial growth factor |